Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	18.29	39.59	33.47
Graham Fair Price	10.94	1850.07	1667.63
PEG	-88.54	0.92	8.01
Price/Book	11.79	1.27	1.14
Price/Cash Flow	-44.00	85.76	-153.15
Prices/Earnings	2.91	14.43	14.02
Price/Sales	13.52	5.00	4.40
Price/FCF	-44.00	85.76	-153.15
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-6.25	0.39	0.41
Operating Margin	-13.88	0.09	0.10
ROA	10.18	0.01	0.01
ROE	0.02	0.02	8.63
ROIC	0.02	0.02	-6.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.27	0.11	158.02
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	0.08	-0.10	15.74
EPS QOQ	0.02	0.16	798.23
FCF QOQ	0.47	3.13	572.48
Revenue QOQ	0.05	0.05	-6.73
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	119.70	99.80	-16.62
Days Sales Outstanding (DSO)	73.35	77.56	5.75
Inventory Turnover	0.75	0.90	19.94
Debt/Capitalization	0.21	0.15	-26.96
Quick Ratio	0.70	0.75	7.73
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2469.97	2629.09	6.44
Cash	134.96	149.08	10.47
Capex	-98.60	-98.73	-0.13
Free Cash Flow	-18.32	38.93	112.48
Revenue	637.52	668.22	4.82
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.43	1.35	-5.87
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.67	3.54	-24.27
Naive Interpretation	Member

06 - Financial Health · Weak

Rating